A simple, specific and reproducible liquid chromatography-electrospray ionization mass spectrometry was developed and validated for the determination of jolkinolide B, a potential antitumor active component isolated from Euphorbia fischeriana, in rat plasma. Chromatographic separation was achieved on a Venusil MP-C18 column using an isocratic elution. Jolkinolide B and osthole (internal standard) were monitored by positive electrospray ionization in the selected reaction monitoring mode. Good linearity (r(2) > 0.996) was achieved by a weighted (1/x(2) ) linear least-squares regression over a concentration range of 6.50-2600 ng/mL. The accuracy and precision of the assay were satisfactory and the method proved to be applicable to pharmacokinetics following a single intravenous bolus injection of jolkinolide B to rats.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/bmc.3000 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
17-hydroxy-jolkinolide B potentiated CTLA4ab therapy through targeting tumor suppression and immune activation by downregulating PD-L1 expression in lung adenocarcinoma.
J Thorac Dis
November 2024
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China.
Background: 17-hydroxy-jolkinolide B (HJB) is a natural diterpenoid compound derived from plants of the family that has anticancer properties against various types of tumors. However, its action and underlying mechanism in lung adenocarcinoma (LUAD) progression remain largely unknown. Thus, this research aimed to explore the role of HJB in LUAD pathogenesis and its clinical significance in tumor therapy.
View Article and Find Full Text PDFJolkinolide B Inhibits Gastric Cancer Growth by Targeting the PANoptosis Molecular Switch Caspase-8.
J Cancer
September 2024
Gansu Provincial Key Laboratory of Environmental Oncology, Lanzhou, Gansu, China.
To elucidate the mechanisms by which Jolkinolide B (JB), derived from Euphorbia fischeriana, suppresses gastric cancer (GC) development, given its known potent antitumor effects and the lack of detailed understanding of its impact and molecular processes in GC. The study utilized both cellular and animal models to investigate the effects of JB on GC. The GC cell lines AGS and MKN45 were used to assess JB's impact on cell growth, proliferation, migration, and invasion.
View Article and Find Full Text PDFJolkinolide B Ameliorates Liver Inflammation and Lipogenesis by Regulating JAK/STAT3 Pathway.
Biomol Ther (Seoul)
November 2024
College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 28160, Republic of Korea.
Hepatic dysregulation of lipid metabolism exacerbates inflammation and enhances the progression of metabolic dysfunction-associated steatotic liver disease (MASLD). STAT3 has been linked to lipid metabolism and inflammation. Jolkinolide B (JB), derived from , is known for its pharmacological anti-inflammatory and anti-tumor properties.
View Article and Find Full Text PDFAnti-Inflammatory, Antibacterial, Anti-Biofilm, and Anti-Quorum Sensing Activities of the Diterpenes Isolated from .
Pharmaceutics
August 2024
Dr. Goya Análisis S.L., Alcalá de Henares, 28805 Madrid, Spain.
This study reports for the first time the isolation of four diterpenoid compounds: 15-Hydroxy-12-oxo-abietic acid (), 12-hydroxyabietic acid (), (-)-Jolkinolide E (), and 15-Hydroxydehydroabietic acid () from (). The findings demonstrate that both the dichloromethane/methanol (DCMECB) extract of and the isolated compounds exhibit significant anti-inflammatory (inhibition of NF-κB activation), antibacterial (primarily against Gram-positive bacteria), and anti-biofilm (primarily against Gram-negative bacteria) activities. Among the isolated diterpenes, compounds and showed notable anti-inflammatory effects, with IC values of 17.
View Article and Find Full Text PDFJolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.
PLoS One
April 2024
Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths. However, the HCC treatment is still challenging. Herein, we aimed to reveal the anti-tumor effect of Jolkinolide B in HCC cell lines Huh-7 and SK-Hep-1.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!